Ted A. Marcuccio

Mr. Marcuccio has more than 15 years of executive experience with leading companies in the pharmaceutical industry. He has played an instrumental role in a wide range of corporate transactions as a business development executive and former investment banker. He has a vast network of contacts in the healthcare and life sciences industry and strong relationships in the capital markets. Prior to Summit Biosciences, Mr. Marcuccio led government and commercial development and alliance management for Meridian Medical Technologies, Inc., a subsidiary of Pfizer Inc., which specialized in emergency use pharmaceuticals delivered with its proprietary auto-injector technology. He was Vice President and Head of Licensing and Business Development for Meridian's former parent company, King Pharmaceuticals, Inc., until its acquisition by Pfizer in 2011. Previous to joining King in 2004, he was Vice President of Vaccines Business Development for Baxter International. Mr. Marcuccio completed an undergraduate degree and a professional certification in accounting (CMA) and earned an MBA from the McCombs School of Business at the University of Texas at Austin.